Author details
Author Richard I |
Available item(s) by this author (172)
sorted by (Issue date descending, Issue date descending, System of projection of the document ascending) | Add the result to the basket | Make a suggestion | Refine your search
Article
Krahn M ; Beroud C ; Labelle V ; Nguyen K ; Bernard R ; Bassez G ; Figarella-Branger D ; Fernandez C ; Bouvenot J ; Richard I ; Ollagnon-Roman E ; Bevilacqua JA ; Salvo E ; Attarian S ; Chapon F ; Pellissier JF ; Pouget J ; Hammouda el H ; Laforet P ; Urtizberea JA ; Eymard B ; Leturcq F | 2009Accès au résumé PubMed / to PubMed abstractArticle
Accès au résumé PubMed / to PubMed abstractArticle
Hackman P ; Marchand S ; Sarparanta J ; Vihola A ; Pénisson-Besnier I ; Eymard B ; Pardal-Fernandez JM ; Hammouda EH ; Richard I ; Illa I ; Udd B ; Hammouda el H | 12/2008Accès au résumé PubMed / to PubMed abstract 05/01/2009 - Des titinopathies décrites hors de Finlande : à propos de 3 nouvelles mutations La titine est une protéine de très grande taille jouant un rôle majeur dans l’appareil contrac[...]Article
Coulis G ; Becila S ; Herrera-Mendez CH ; Sentandreu MA ; Raynaud F ; Richard I ; Benyamin Y ; Ouali A | 2008Article
Muscular dystrophies (MD) are a group of genetic diseases characterized by progressive muscle degeneration and weakness. Muscle atrophy is a very common clinical feature of these pathologies. In an attempt to identify potential therapeutic targe[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Lostal W ; Bourg N ; Roudaut C ; Miyake K ; Mcneil P ; Bartoli M ; Richard I | 2008Dysferlinopathies are recessive muscular disorders caused by defects in dysferlin. Genetic mutations are responsible for two major phenotypes: Limb Girdle Muscular Dystrophy type 2B and Distal Miyoshi Myopathy. These skeletal muscle diseases are[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Navarro C ; Farini A ; Meregalli M ; Belicchi M ; Parolini D ; Razini P ; Krahn M ; Wein N ; Bourg N ; Bartoli M ; Richard I ; Torrente Y | 2008Mutations in gene encoding Dysferlin are involved in Limb-gird Muscular Dystrophy type 2B (LGMD-2B) and and Miyoshi myopathy (MM), both diseases are characterized by progressive weakness and wasting of skeletal muscles. Dysferlin is abundantly e[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Daniele N ; Laure L ; Suel-Petat L ; Roudaut C ; Ouali A ; Bartoli M ; Richard I | 2008INTRODUCTION Les dystrophies musculaires sont des maladies génétiques caractérisées par une dégénérescence musculaire progressive. L'atrophie fréquemment associée à ces pathologies participe à la perte de force du tissu musculaire. OBJECTIFS Not[...]Article
Benayoun B ; Baghdiguian S ; Lajmanovich A ; Bartoli M ; Daniele N ; Gicquel E ; Bourg N ; Raynaud F ; Pasquier MA ; Suel L ; Lochmuller H ; Lefranc G ; Richard I | 2008Accès au résumé PubMed / to PubMed abstractArticle
Bartoli M ; Gicquel E ; Barrault MF ; Soheili T ; Malissen M ; Malissen B ; Vincent-Lacaze N ; Perez N ; Udd B ; Danos O ; Richard I | 2008Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Blandin G ; Marchand S ; Noulet F ; Gicquel E ; Barrault L ; Boucheteil J ; Formstecher E ; Meil A ; Collura V ; Daniele N ; Bartoli M ; Richard I | 2008To improve our understanding of the molecular pathways involved in the pathogenesis of muscular dystrophies and to allow identification of specific processes that may lead to future therapeutic strategies, we chose a domain-based yeast-two hybri[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Sarparanta J ; Vihola A ; Hackman P ; Richard I ; Udd B | 2008Tibial muscular dystrophy (TMD) is a dominant late onset distal myopathy caused by mutations in M-line titin. In the few homozygotes known, the same mutations lead to the different, more severe limb-girdle muscular dystrophy LGMD2J. Most of the [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Bartoli M ; Gicquel E ; Barrault L ; Soheili T ; Malissen M ; Malissen B ; Udd B ; Danos O ; Richard I | 2008Limb girdle muscular dystrophy type 2D (LGMD2D, OMIM600119) is a genetic progressive myopathy that is caused by mutations in the human ?-sarcoglycan gene (SGCA). We introduced in mice the most prevalent LGMD2D mutation, R77C. Unexpectedly, we ob[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Fougerousse F ; Giannesini B ; Durand M ; Guerchet N ; Bendahan D ; Cozzone PJ ; Richard I | 2008We aim at characterizing muscle function in a cohort of different animal models for LGMD2 using mechanical parameters in several isolated muscles. Non invasive techniques will also be applied such as grip, escape or wire tests and measurements o[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Friedrich A ; Garnier N ; Blandin G ; Bettler E ; Richard I ; Moulinier L ; Poch O | 2008The MS2PH project (from Structural Mutation to Human Pathologies Phenotypes) aims at investigating how mutations impact protein structures and to which extent this change could affect pathological phenotypes. This project is part of the Decrypth[...]Article
Colloque jeunes chercheurs (7 mars 2008; EVRY - Centre conférence Génocentre Evry) ; Friedrich A ; Garnier N ; Blandin G ; Bettler E ; Richard I ; Moulinier L ; Poch O | 2008The MS2PH project (from Structural Mutation to Human Pathologies Phenotypes) aims at investigating how mutations impact protein structures and to which extent this change could affect pathological phenotypes. This project is part of the Decrypth[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Urtizberea JA ; De Munain LA ; Mignard C ; Boué P ; Doppler V ; Hogrel JY ; Stockholm D ; Payan C ; Poza J ; Bousquet N ; Richard I ; Fougerousse F ; Calpain Study Group | 2008The determination of the natural history is a prerequisite to any future clinical trial in a given myopathy. This is particularly true in calpainopathy where the individual disease progression may markedly vary and where the course itself seems [...]Article
Collectif ; Sarparanta J ; Vihola A ; Marchand S ; Blandin G ; Hackman P ; Ehler E ; Richard I ; Udd B | 2008Article
Collectif ; Richard I ; Bartoli M ; Gicquel E ; Barrault L ; Soheili T ; Malissen M ; Malissen B ; Udd B ; Danos O | 2008Article
Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Krahn M ; Wein N ; Lostal W ; Bourg-Alibert N ; Nguyen K ; Courrier S ; Vial C ; Labelle V ; De Petris D ; Borges A ; Mattéi MG ; Roudaut C ; Miyake K ; Mcneil P ; Cau P ; Leturcq F ; Bartoli M ; Richard I | 2008Primary dysferlinopathies are a heterogeneous group of autosomal recessive muscular dystrophies, caused by mutations in the large-sized DYSF gene encoding dysferlin. Dysfunction of dysferlin causes deficient sarcolemmal repair and leads to muscl[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Soheili T ; Gicquel E ; Barrault L ; Bartoli M ; Richard I | 2008Sarcoglycanopathies are recessive muscular disorders caused by defects in a group of transmembrane proteins, known as sarcoglycans, and part of the dystrophin-associated complex. Mutations in the ?, ?, ? and ? sarcoglycan genes lead to a similar[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Charton K ; Daniele N ; Suel-Petat L ; Udd B ; Richard I | 2008Titin is a giant protein expressed in both skeletal muscles and heart. Titin spans from the Z-disc to the M-line of striated muscle sarcomeres. Several pathogenic mutations were identified in its last two exons causing the phenotype of late onse[...]Article
Bartoli M ; Poupiot J ; Vulin A ; Fougerousse F ; Arandel L ; Daniele N ; Roudaut C ; Noulet F ; Garcia L ; Danos O ; Richard I | 05/2007Accès au résumé PubMed / to PubMed abstract 29/03/2007 - Effet bénéfique d’un blocage de la myostatine chez une souris modèle de LGMD2A. La myostatine est une protéine produite par l’organisme et destinée à limiter naturellement l[...]